Mer­ck ad­mits cy­ber­at­tack is hav­ing an im­pact on re­search, man­u­fac­tur­ing — we're just not sure how big

Mer­ck is still grap­pling with just how much dam­age they’ve in­curred as a col­lat­er­al vic­tim of the Not­Petya at­tack one month ago. And as a di­rect con­se­quence, they’re cut­ting their prof­it out­look and sig­nal­ing de­lays with some prod­uct sup­ply or­ders.

The phar­ma gi­ant dis­closed the news this morn­ing in their earn­ings re­port, with CFO Rob Davis telling an­a­lysts the com­pa­ny is still “as­sess­ing the full im­pact.”  But it has clear­ly had an im­pact on the num­bers. “The guid­ance would have been high­er with­out the cy­ber­at­tack,” Davis added.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.